{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:48:43Z","timestamp":1789469323200,"version":"build-2803163510"},"reference-count":35,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung cancer is among the most aggressive types of malignant tumors that contributes to cancer\u2010associated deaths worldwide with a high occurrence and fatality rate. Histone deacetylase 2 (HDAC2), prevent the aberrant transcription of a number of genes that are primarily responsible for controlling the cell cycle, cell proliferation, and signaling pathways in numerous cancers. Previous studies reported the role of HDACs and YY1 in the growth and development of several cancers. Although, it is noteworthy that remarkable efforts have been taken for the treatment of lung cancer using molecularly targeted therapies and chemotherapeutic agents, but the outcome is still poor for this critically persistent cancer. Therefore, the aim of the present study is to identify an efficacious, novel therapeutic biomarkers for the successful diagnosis of lung cancer at the early stage of the disease and the molecular insights involved. In the present study, qPCR and western bot data revealed that the expression level of HDAC2 and YY1 were upregulated in the cell lines and tumor samples of lung cancer patients. Moreover, MTT, qPCR, western blot, cell cycle analysis, and migration assays showed that inhibition of HDAC2 reduced YY1 expression, similarly, depletion of YY1 using knockdown approach inhibited the proliferation, migration, invasion, and blockage of the cell cycle by suppressing c\u2010Myc in lung cancer cell lines. In conclusion, the current study findings support the notion that HDAC2's anticancer role was attributed through YY1 regulation by targeting c\u2010Myc and could act as potential novel candidate biomarker for the lung cancer diagnosis.<\/jats:p>","DOI":"10.1002\/tox.23825","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:50:50Z","timestamp":1683766250000},"page":"1989-2001","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The\n                    <scp>HDAC2<\/scp>\n                    \/\n                    <scp>YY1<\/scp>\n                    \/\n                    <scp>c\u2010Myc<\/scp>\n                    signaling axis regulates lung cancer cell migration and proliferation"],"prefix":"10.1002","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4076-6620","authenticated-orcid":false,"given":"Arshad","family":"Ali","sequence":"first","affiliation":[{"name":"GMU\u2010GIBH Joint School of Life Sciences, The Guangdong\u2010Hong Kong\u2010Macau Joint Laboratory for Cell Fate Regulation and Diseases Guangzhou Medical University  Guangzhou China"},{"name":"School of Life Science Northwestern Polytechnical University  Xian China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4972-5515","authenticated-orcid":false,"given":"Ayaz","family":"Ali","sequence":"additional","affiliation":[{"name":"Aberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences University of Aberdeen  Aberdeen UK"},{"name":"Cardiovascular and Mitochondrial Related Disease Research Center Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation  Hualien Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5058-5807","authenticated-orcid":false,"given":"Hema S.","family":"Devi","sequence":"additional","affiliation":[{"name":"Cardiovascular and Mitochondrial Related Disease Research Center Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation  Hualien Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0666-8517","authenticated-orcid":false,"given":"Jayasimha R.","family":"Daddam","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Tulane School of Medicine Tulane University  New Orleans USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabiah","family":"Sarwar","sequence":"additional","affiliation":[{"name":"School of Life Sciences University of Aberdeen  Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farheen Khan","family":"Badrealam","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science United Arab Emirates University  Al Ain United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21609"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"issue":"18","key":"e_1_2_8_4_1","first-page":"5972","article-title":"MicroRNA\u2010217 alleviates development of non\u2010small cell lung cancer by inhibiting AKT3 via PI3K pathway","volume":"22","author":"Qi YJ","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21208"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2013.22.Sup17.S15"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210610"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-3-5"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202000131"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i6.813"},{"issue":"12","key":"e_1_2_8_11_1","article-title":"Inhibition of HDACs suppresses cell proliferation and cell migration of gastric cancer by regulating E2F5 targeting BCL2","volume":"11","author":"Ali A","year":"2021","journal-title":"Life (Basel)"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-015-0379-y"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.S1.89"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.5b01067"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867327666200203113926"},{"issue":"1","key":"e_1_2_8_16_1","first-page":"116","article-title":"Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti\u2010angiogenesis genes in aggressive human TNBC cells","volume":"55","author":"Maiti A","year":"2019","journal-title":"Int J Oncol"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2016.02.006"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31255"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17196"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.v16.i3-4.30"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404583"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10234"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.07.026"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209080"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4688"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2017020473"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201968"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.7.4323-4330.1995"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1043-1"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0744"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.17.5979-5991.2001"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.181"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006281"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.1.1"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.06.006"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.06.019"}],"container-title":["Environmental Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/tox.23825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T08:29:04Z","timestamp":1762590544000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/tox.23825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1002\/tox.23825"],"URL":"https:\/\/doi.org\/10.1002\/tox.23825","archive":["Portico"],"relation":{},"ISSN":["1520-4081","1522-7278"],"issn-type":[{"value":"1520-4081","type":"print"},{"value":"1522-7278","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"assertion":[{"value":"2023-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}